You are here: Home / Archives for Cell

The XCell-Center Treats its 2000th Stem Cell Patient in Germany

May 20, 2012 By Leave a Comment

Dusseldorf, Germany (PRWEB) December 21, 2009

The XCell-Center is pleased to report treating its 2000th stem cell patient at its state-of-the-art clinic in Dusseldorf, Germany.

Since treating its first patient in early 2007, the XCell-Center has emerged as Europe?s leading stem cell therapy provider. Now, patients from all over the world visit the XCell-Center seeking treatment for spinal cord injury, diabetes, cerebral palsy, heart disease, autism, various eye diseases and other neurological disorders like stroke and Parkinson?s. Many of them have experienced remarkable improvements following treatment.

?Now, I am walking like I was before I had Parkinson’s and my shaking is more under control,? said Jon Andresen about five months after his treatment.

The treatment process consists of three steps: bone marrow collection, laboratory processing and stem cell implantation.

Bone Marrow Collection

On the first day, bone marrow is collected from the patient?s iliac crest (hip bone) using thin-needle mini-puncture under local or general anesthesia (mainly in children). The entire procedure normally takes about 30 minutes. Each patient is treated with his or her own stem cells.

Laboratory Processing

The next day, the stem cells are processed from the bone marrow in a state-of-the-art, government approved (cGMP) laboratory. In the lab, both the quantity and quality of the stem cells are measured by sophisticated, analytical instruments.

Stem Cell Implantation

On the third day, the stem cells are implanted using a variety of methods, each designed to optimize placement of the cells as safely and closely as possible to the damaged organ or tissue.

Lumbar Puncture ? Stem cells are injected into the spinal fluid under local or general anesthesia to treat neurological diseases/disorders in the brain and the spinal cord.

Surgical Implantation ? Stem cells are implanted directly into the brain under general anesthesia using MRI/PET/CT mapping and a high tech navigation system allowing the cells to be placed with the highest accuracy while minimizing the risks.

Neuro-endoscopic Autologous Stem Cell Implantation (NEASCI?) ? Stem cells are implanted under general anesthesia into the cerebral fluid space(s) using a mini-endoscope and catheter with MRI/PET/CT mapping.

Angiography ? Stem cells are implanted into the pancreatic artery for diabetes or the coronary arteries for heart disease using a fine wire (catheter) under local anesthesia.

Direct Injection ? Stem cells are injected directly into the target tissue such as leg muscles for neuropathy or the joint(s) for arthritis.

Intravenous Injection ? When other implantation methods are not possible due to safety considerations or the damage is diffuse, the stem cells can be injected into the bloodstream intravenously.

?… we started noticing changes in Christopher?s speech pattern. Until then he only spoke in fragmented sentences but now he has begun talking in complete sentences,? noted Ritu Giacobbe, the mother of a 13 year-old boy who was first treated at the XCell-Center for cerebral palsy in August, 2008.

Patients who are interested in stem cell therapy at the XCell-Center can start by completing the Medical Information Form online: http://www.xcell-center.com/request-information.aspx

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law and European guidelines. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germamy

Phone: 1-866-680-8202 (USA Toll-Free)

Filed Under: Alzheimer's Disease Tagged With: , , , , , ,

Stem Cell Therapy News Now Available on Twitter

April 23, 2012 By Leave a Comment

Dusseldorf, Germany (PRWEB) January 28, 2010

The XCell-Center announces the official launch of its stem cell therapy news campaign on Twitter.com to meet the demand of prospective and treated patients who wish to receive real-time updates on treatment success stories, newly available treatments and other newsworthy events.

To start receiving updates today, please visit http://twitter.com/xcellcenter

Since treating its first patient in early 2007, the XCell-Center has emerged as Europe?s leading stem cell therapy provider. In December 2009, the XCell-Center attained ISO 9001 quality management certification. By implementing ISO standards, the XCell-Center demonstrates its commitment to excellence in safety and quality for the benefit of its patients.

Patients from all over the world visit the XCell-Center seeking treatment for spinal cord injury, diabetes, cerebral palsy, heart disease, autism, various eye diseases and other neurological disorders like stroke and Parkinson?s. Many of them have experienced remarkable improvements following treatment.

?Jannat was in very poor condition? Now, one year after her treatment, Jannat can speak clearly and fluently. ? She is even able to stand with the aid of a support. ?Today, we are once again in D

Filed Under: Alzheimer's Disease Tagged With: , , , , ,

Majority of Parkinson?s Patients Improved After German Stem Cell Treatment

April 19, 2012 By Leave a Comment

Dusseldorf, Germany, (PRWEB) February 4, 2010

The XCell-Center, Europe?s leading stem cell therapy provider has released results from a follow-up study of 50 Parkinson?s disease patients treated with autologous bone marrow stem cells. Overall, almost 60% improved following treatment.

These results support the premise that patients with Parkinson?s disease can be treated safely and effectively with autologous stem cell therapy.

The most common improvements reported by patients were decreased rigidity (74%) and better walking/gait (over 80%).

?Two months after the stem cell therapy, I had a checkup for a hole in my eardrum that had been there for several years and it was healed up completely! As for the Parkinson’s symptoms, I am much stronger. I still fall occasionally but nothing compared to before therapy. People tell me that I am talking much better. I am blinking and smiling and I have more facial expression? My ability to use utensils at mealtime is almost back to normal,? said Mr. Herman Engman, who was treated in January 2009.

More than half of the patients who improved reported decreased tremors while more than 60% experienced better speech. Approximately 60% of the patients surveyed had their improvement confirmed by their own physician.

Complete results are available at http://www.xcell-center.com/treatments/results/parkinson-s.aspx

?Now, I am walking like I was before I had Parkinson’s and my shaking is more under control? I am sleeping longer at night and have also gained 10 pounds? This is the first time in four years that I have been able to gain any weight,? stated Mr. John Andresen. Mr. Andresen was treated in July 2009.

The treatment begins by collecting a small amount bone marrow from the patient?s hip via thin needle mini-puncture under local anesthesia. The stem cells are separated from the bone marrow at the XCell-Center?s EU certified cGMP laboratory, where they are counted and their vitality is confirmed. The last step consists of inserting a fine spinal needle between the patient?s L4 and L5 vertebrae and injecting the stem cells into the cerebrospinal fluid which flows into the brain.

The cost for Parkinson?s treatment starts at around 7,545 Euros.

In 2009, the XCell-Center treated its first patients via stereotactic autologous stem cell implantation. This innovative technique allows neurosurgeons to implant stem cells directly into a patient?s brain, thus achieving more accurate targeting of stem cells than with other implantation methods such as intrathecal injection. All XCell-Center patients are treated with their own bone marrow-derived stem cells.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germamy

E-Mail: info(at)xcell-center(dot)de

Phone: 1-866-680-8202 (USA Toll-Free)

Filed Under: Alzheimer's Disease Tagged With: , , , , , , , ,

Safety Follow-up of Adult Stem Cell Patients Yields Promising Results

April 15, 2012 By Leave a Comment

Dusseldorf, Germany (PRWEB) February 11, 2010

The XCell-Center has completed a promising safety follow-up of 870 patients who were treated by lumbar puncture for various indications such as spinal cord injury, Parkinson’s disease, cerebral palsy, and more. Patients were surveyed 10 days after treatment and again after 3 months.

A lumbar puncture is a procedure by which a patient?s own stem cells are injected into their spinal fluid under local or general anesthesia (mainly in children). Prior to the lumbar puncture, bone marrow is collected from the patient?s iliac crest (hip bone) using thin-needle mini-puncture under local or general anesthesia. The stem cells are then separated from the bone marrow using a proprietary process in a cGMP certified laboratory.

?Overall, we found that the transplantation of stem cells via lumbar puncture appears to as safe as common lumbar puncture procedures used for other purposes such as diagnostics. Therefore, we?ve concluded that lumbar puncture is a safe and non-invasive procedure by which to inject stem cells into a patient’s intrathecal space (spinal fluid),? stated Dr. Johannes de Munter, Director Research and Development XCell-Center Cologne and Dusseldorf Germany.

The most common side-effects experienced by patients were headache and backache; occurring in approximately 1 out of 5 patients. The researchers determined that headaches were a relative side effect due to the lumbar puncture procedure itself and were unrelated to the stem cells. Leg pain and nausea were reported by roughly 10% of those treated. 98% of patients reported that their side-effects subsided in less than 10 days.

The Complete results may be viewed here: http://www.xcell-center.com/media/89867/safety%20database%20lp%20febr2010.pdf

About the XCell-Center:

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

For more information on Stem Cell Therapy: XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germany

E-Mail: info(at)xcell-center(dot)de

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)

Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###



Filed Under: Alzheimer's Disease Tagged With: , , , , , , , ,

XCell-Center Presents Impressive Results from Cerebral Palsy Stem Cell Treatment

April 5, 2012 By Leave a Comment

Dusseldorf, Germany, (PRWEB) March 8, 2010

The XCell-Center has released impressive results from a follow-up study of 100 cerebral palsy patients treated with autologous bone marrow stem cells. Overall, 67% improved following treatment.

This improvement rate is consistent with the rate released in September 2009 for 45 cerebral palsy patients and provides further support to the premise that patients with cerebral palsy can be treated safely and effectively with autologous stem cell therapy.

The most common improvement, reported over 70% of the time, was a decrease in arm and hand spasticity. 60% of patients experienced improvements in hand and finger motor skills, coordination, and general use.

?Griffin underwent his first stem cell treatment at the XCell-Center in April 2009. Cognitive improvements materialized after about 3 weeks and physical improvements started at 3 – 6 months. Griffin’s muscle tone improved along with his attention span and ability to engage others. He no longer required Botox which he needed twice before stem cell therapy,? said Carol Wayland, the mother of Griffin Perez, a patient who continues to improve after his second stem cell treatment in September, 2009.

Griffin?s full story can be read online here: http://www.xcell-center.com/patient-stories/cerebral-palsy/griffin-perez.aspx

Leg and foot coordination improved in nearly half of the patients. Approximately 50% had reduced lower limb spasticity. Over 40% were able to walk better.

Speech improved in almost 60% of patients. 1 in 5 showed improved cognition.

?Since they include many more patients with greater levels of individual improvement, these new results are even more encouraging to us than those released for 45 cerebral palsy patients in 2009. We are now looking forward to seeing results for our newly developed neuro-endoscopic autologous stem cell implantation technique (NEASCI?) which we expect to deliver even more impressive results than these,? stated Dr. Ute Tamaschke, the XCell-Center?s pediatric neurosurgeon. NEASCI results are anticipated to be released in 2011.

Interested parties may visit the XCell-Center website to view the complete results: http://www.xcell-center.com/treatments/results/cerebral-palsy.aspx

Each treatment begins by collecting a small amount bone marrow from the patient?s hip via thin needle mini-puncture. The stem cells are separated from the bone marrow at the XCell-Center?s EU certified cGMP laboratory, where they are counted and their vitality is confirmed. The last step consists of inserting a fine spinal needle between the patient?s L4 and L5 vertebrae and injecting the stem cells into the cerebrospinal fluid which flows into the brain. The cost for this cerebral palsy treatment is 9,000 Euros.

NEASCI? treatments start at 17,800 Euros.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

Since its inauguration in 2007, the XCell-Center has treated more than 2,500 patients.

For safety data please visit: http://www.xcell-center.com/media/89867/safety%20database%20lp%20febr2010.pdf

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germamy

E-Mail: info(at)xcell-center(dot)de

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)

Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###



Find More Alzheimer Disease Press Releases

Filed Under: Alzheimer's Disease Tagged With: , , , , , , , , ,

Statistics Confirm Spinal Cord Injury Patients Improving After Stem Cell Therapy

March 18, 2012 By Leave a Comment

Dusseldorf, Germany (PRWEB) April 28, 2010

The XCell-Center has released encouraging results from a follow-up study of 140 spinal cord injury patients treated with autologous bone marrow stem cells. Overall, nearly 6o% improved following treatment.

These results are consistent with those presented in October, 2009 and they continue to support the premise that spinal cord injury patients can be treated safely and effectively with autologous stem cell therapy.

Patients with measured ASIA scores saw average improvements of about 10% in ASIA motor score, and approximately 20% in ASIA pin prick and light touch measurements.

The most common improvement, reported by almost 7 out of every 10 patients, was the return of feeling to the hands, feet, arms, legs or trunk. Muscle strength and endurance improved in over 65% of those treated and more than half reported a decrease in muscle spasticity.

?Since treatment, I have regained feeling in my legs. … My bowels are working easier than before and my hips are becoming more stable. Pain in my left leg is down by half and I have been able to stop taking pain pills. Sometimes there is no pain at all. … I would recommend this treatment to anyone who is considering it,” said Harold Poxleitner, a former logger who was injured over 40 years ago and who underwent treatment in November 2009.

Mr. Poxleitner’s full story can be read here: http://www.xcell-center.com/patient-stories/spinal-cord/harold-poxleitner.aspx

40% of those who improved experienced better bladder control and over 30% had better bowel control. About a quarter had better erections and a small number of those regained complete sexual function.

?These laudable results illustrate the significant impact that stem cell therapy has on the lives of most spinal injury patients we treat,? remarked Dr. Hans de Munter, the XCell-Center?s Chief Scientific Officer.

Full spinal cord injury treatment results can be viewed here: http://www.xcell-center.com/treatments/results/spinal-cord-injury.aspx

The treatment begins by collecting a small amount bone marrow from the patient?s hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center?s EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure, which consists of injecting the stem cells into the patient?s spinal fluid using a spinal needle under local anesthesia.

The cost for spinal cord injury treatment starts at 7,545 Euros.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

Since its inauguration in 2007, the XCell-Center has treated more than 2,500 patients. For safety data please visit: http://www.xcell-center.com/media/89867/safety%20database%20lp%20febr2010.pdf

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

Twitter: http://www.twitter.com/xcellcenter

Facebook: http://www.facebook.com/XCellCenter

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germamy

E-Mail: info@xcell-center.de

Phone: 1-866-680-8202 (USA Toll-Free)

Filed Under: Alzheimer's Disease Tagged With: , , , , , , , , , ,

Discovery of Stem Cell Illuminates Human Brain Evolution, Points To Therapies

March 8, 2012 By Leave a Comment


San Francisco, CA (Vocus) May 26, 2010

UCSF scientists have discovered a new stem cell in the developing human brain. The cell produces nerve cells that help form the neocortex ? the site of higher cognitive function — and likely accounts for the dramatic expansion of the region in the lineages that lead to man, the researchers say.

Future studies of these cells are expected to shed light on developmental diseases such as autism and schizophrenia and malformations of brain development, including microcephaly, lissencephaly and neuronal migration disorders, they say, as well as age-related illnesses, such as Alzheimer?s disease.

Studies also will allow scientists to track the molecular steps that the cell goes through as it evolves into the nerve cell, or neuron, it produces. This information could then be used to prompt embryonic stem cells to differentiate in the culture dish into neurons for potential use in cell-replacement therapy.

The study is reported in a recent issue of the journal Nature, (vol. no. 464, 554-561; issue 7288).

?This discovery has the potential to transform our understanding of the development and evolution of the human neocortex, the most uniquely human part of the central nervous system,? says the senior author of the study, neurologist Arnold Kriegstein, MD, PhD, director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.

?It also should inform our understanding of developmental diseases and advance the creation of cell-based therapies. Many neurological diseases develop in neurons or the neural circuits between them. If we?re going to understand how these disorders develop, we have to better understand how the human and primate cerebral cortex develops.?

In rodents and humans, the developing cortex contains a layer of neural stem cells called radial glial cells that resides near the fluid-filled ventricles and produces cells that are precursors to neurons. These precursor neurons further proliferate in a region known as the subventricular zone (SVZ), to increase their numbers, and then differentiate into newborn neurons. The neurons then migrate along radial glial fibers up to the neocortex, where they help form the tissue that is the site of sensory perception, motor commands, spatial reasoning, conscious thought and language.

In human and nonhuman primates, however, the SVZ has a massively expanded outer region, known as the outer subventricular zone (OSVZ). About 20 years ago, scientists presumed that the OSVZ also contained stem cells, but until now they have lacked evidence.

In the current study, lead authors David V. Hansen, PhD, a postdoctoral fellow, and Jan H. Lui, a graduate student in the Kriegstein lab, examined the OSVZ, using new labeling and tracking techniques to follow individual cells and their progeny over time in cultured tissue slices from fetal cortex tissue that had been donated for research.

They characterized two kinds of cells within the region — both the novel neural stem cell and its daughter cell, known as the transit amplifying cell. The stem cell closely resembles the radial glial cell in structure and behavior and, like the radial glia, has radial fibers which newborn neurons migrate along up to the neocortex.

The region is a busy hub of cell proliferation. The stem cell undergoes asymmetrical cell division, giving rise to two distinct daughter cells — one a copy of the original stem cell, the other a transit amplifying cell. The transit amplifying cell undergoes multiple rounds of symmetrical divisions before all of its daughter cells begin the process of differentiating into neurons.

?We are very interested in understanding how these modes of division are regulated,? says Kriegstein. ?We suspect that faults in cell-cycle regulation account for a variety of developmental brain diseases.?

More broadly, he says the team wants to understand how the new stem cells compare to radial glial cells and how the two sets of neurons they produce integrate in the neocortex. ?Neurons are probably being generated in both the SVZ and OSVZ at once,? he says. ?They likely end up in the same layer of the neocortex as they migrate into position and start forming circuits.

?This suggests to us that there may be a mosaic of cell types in the human neocortex, in which there are cells that originate in the traditional zone and cells produced in the newer zone that intermix in the cortex. The complexity of primate neocortex may be significantly increased by the interaction of the evolutionarily-speaking ?younger? neurons with those originating in the more primitive zone.?

The massive number of cells within the OSVZ of humans ?tells us we have to be careful when modeling human brain diseases in mice,? says Kriegstein. ?Especially in the neocortex — the most highly developed part of the brain in primates and humans ? there are going to be important differences between rodents and humans.?

The other co-author of the study was Philip R. L. Parker, a graduate student in the Kriegstein lab.

The study was funded by grants from the California Institute for Regenerative Medicine and the Bernard Osher Foundation.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Related links:

Nature paper:

http://www.nature.com/nature/journal/v464/n7288/full/nature08845.html

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF

http://stemcell.ucsf.edu/

###





Find More Alzheimer Disease Press Releases

Filed Under: Alzheimer's Disease Tagged With: , , , , , , , ,

COPD Patient Breathes Easy After Stem Cell Therapy in Germany

January 23, 2012 By Leave a Comment


Dusseldorf, Germany (PRWEB) September 10, 2010

After stem cell therapy for chronic obstructive pulmonary disease (COPD) at the XCell-Center in Dusseldorf, Germany, post-treatment tests confirm patient’s remarkable physical improvements.

Frank Wade, a retired chauffeur from Sussex, England, is indeed breathing easier following his stem cell therapy for COPD at the XCell-Center this past June. Mr. Wade also worked many years as a compositor for a printing company where he handled lead and other dangerous chemicals that he feels may have contributed to his COPD.

“I was taken ill with pneumonia in June 2009 and whilst in hospital I was diagnosed with COPD but I had had breathing problems since 2008 and this was being looked into by my doctor. I was very out of breath and weak and gradually became unable to carry out normal day to day activities. I couldn’t do any gardening, cooking or decorating; I wasn’t well enough to go on holiday. I used to sit in a chair doing very little. I wasn’t able to shower without any assistance. I seldom left my home,” remarked Mr. Wade regarding the progression of his illness.

The stem cells were implanted via minimally invasive angiography into Mr. Wade’s pulmonary arteries by Dr. Christian Beythien, the XCell-Center’s Head Cardiologist and Medical Director. During this procedure, a special catheter (thin hollow wire) is inserted into the femoral vein and then guided via x-ray scanning through the heart and into each pulmonary artery where 50% of the stem cells are implanted into the right pulmonary artery and 50% into the left. The entire procedure normally takes about 90 minutes.

When asked about his progress since undergoing stem cell therapy, Mr. Wade replied, “Three weeks after treatment, I went to see my doctor in a London hospital. He carried out two tests and noted an improvement since my last (pre-stem cell therapy) visit. Since the stem cell treatment, I have stopped using the inhalers which I used twice a day. I can now go on short walks. I can also go out with my friends and my breathing is so much improved. I’ve even felt able recently to cook a meal which I haven’t done in over a year. ” He went on to add, “My physiotherapist is amazed at how well I am doing for someone with COPD. I also had my SATS taken recently and they were 98%; a great improvement.”

Each COPD treatment begins by collecting a small amount bone marrow from the patient’s hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center’s EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure.

The price of the COPD angiography treatment is 13,500 Euros. IV treatment is 5,545 Euros.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

Since its inauguration in 2007, more than 3,500 patients have been treated.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

Twitter: http://www.twitter.com/xcellcenter

Facebook: http://www.facebook.com/XCellCenter

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germany

E-Mail: info(at)xcell-center(dot)de

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)

Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###





Filed Under: Alzheimer's Disease Tagged With: , , , , , , , ,

Stem Cell Treatment Gets Arthritis Patient From New Zealand Back On Track

January 15, 2012 By Leave a Comment


Dusseldorf, Germany (PRWEB) September 23, 2010

After being sidelined for years by painful knee arthritis, Malcolm Pasley is once again jogging and doing squats following stem cell therapy at the XCell-Center in Cologne, Germany.

In early 2010, after reviewing his knee x-rays, Mr. Pasley’s orthopedist gave him the bad news. He had developed osteoarthritis in both knees and eventually, he would be forced to get a knee replacement; something Mr. Pasley definitely did not want.

“I started researching on the internet about stem cells as I had never heard of them before. I got information about how they do it in countries like Germany. After speaking to an XCell-Center representative, I weighed up the expense against the possibility of fixing up my knees and decided to give it a go,” said Mr. Pasley.

After obtaining detailed computed tomography images of Mr. Pasley’s knee with the XCell Imaging Center’s GE Discovery HD CT750 CT High-Definition & Ultra-Low-Dose CT scanner, the clinic’s orthopedist carefully injected the stem cells into the damaged areas in both knees under local anesthesia.

Commenting on his progress since treatment, Mr. Pasley stated, “It is now about 7 weeks ago that the stem cells were administered and I notice a huge improvement in both knees while at work. I can do squats and go jogging ,which previously I had not been able to for a few years without my knee swelling up quite large. It has stopped swelling altogether. I used to go skiing and do karate which are two sports I probably could do again. I now do a lot of cycling with no knee pains or a swollen knee which is great.”

Each arthritis treatment begins by collecting a small amount bone marrow from the patient’s hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center’s EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure.

As in Mr. Pasley’s case, pre-treatment MRI and/or CT imaging will be performed when necessary. Implantations can also be performed under CT scanning whenever the medical circumstances require it.

The price for orthopedics treatment is 7,995 Euros for one extremity and 500 Euros for each additional extremity. Treatment under CT scanning starts at 9,454 Euros.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

Since its inauguration in 2007, more than 3,500 patients have been treated.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

Twitter: http://www.twitter.com/xcellcenter

Facebook: http://www.facebook.com/XCellCenter

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germany

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)

Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###





Filed Under: Alzheimer's Disease Tagged With: , , , , , , , , ,

Stem Cell Treatment Gets Arthritis Patient From New Zealand Back On Track

January 15, 2012 By Leave a Comment


Dusseldorf, Germany (PRWEB) September 23, 2010

After being sidelined for years by painful knee arthritis, Malcolm Pasley is once again jogging and doing squats following stem cell therapy at the XCell-Center in Cologne, Germany.

In early 2010, after reviewing his knee x-rays, Mr. Pasley’s orthopedist gave him the bad news. He had developed osteoarthritis in both knees and eventually, he would be forced to get a knee replacement; something Mr. Pasley definitely did not want.

“I started researching on the internet about stem cells as I had never heard of them before. I got information about how they do it in countries like Germany. After speaking to an XCell-Center representative, I weighed up the expense against the possibility of fixing up my knees and decided to give it a go,” said Mr. Pasley.

After obtaining detailed computed tomography images of Mr. Pasley’s knee with the XCell Imaging Center’s GE Discovery HD CT750 CT High-Definition & Ultra-Low-Dose CT scanner, the clinic’s orthopedist carefully injected the stem cells into the damaged areas in both knees under local anesthesia.

Commenting on his progress since treatment, Mr. Pasley stated, “It is now about 7 weeks ago that the stem cells were administered and I notice a huge improvement in both knees while at work. I can do squats and go jogging ,which previously I had not been able to for a few years without my knee swelling up quite large. It has stopped swelling altogether. I used to go skiing and do karate which are two sports I probably could do again. I now do a lot of cycling with no knee pains or a swollen knee which is great.”

Each arthritis treatment begins by collecting a small amount bone marrow from the patient’s hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center’s EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure.

As in Mr. Pasley’s case, pre-treatment MRI and/or CT imaging will be performed when necessary. Implantations can also be performed under CT scanning whenever the medical circumstances require it.

The price for orthopedics treatment is 7,995 Euros for one extremity and 500 Euros for each additional extremity. Treatment under CT scanning starts at 9,454 Euros.

About the XCell-Center

The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.

The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s, Alzheimer’s and several eye diseases.

Since its inauguration in 2007, more than 3,500 patients have been treated.

For more information on Stem Cell Therapy:

XCell-Center Website: http://www.xcell-center.com

Twitter: http://www.twitter.com/xcellcenter

Facebook: http://www.facebook.com/XCellCenter

XCell-Center GmbH

at the Institute for Regenerative Medicine

Am Heerdter Krankenhaus 2

40549 Dusseldorf, Germany

Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)

Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)

###





Filed Under: Alzheimer's Disease Tagged With: , , , , , , , , ,
« Older Posts